Relapsing Multiple Sclerosis (RMS) Overview

Save information for later
Sign Up

Learn About Relapsing Multiple Sclerosis (RMS)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Relapsing Multiple Sclerosis (RMS) Local Doctors?
Frederik Barkhof
Elite in Relapsing Multiple Sclerosis (RMS)
Elite in Relapsing Multiple Sclerosis (RMS)
UCL Queen Square Institute Of Neurology, 
London, ENG, GB 

Frederik Barkhof practices in London, United Kingdom. Mr. Barkhof is rated as an Elite expert by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Multiple Sclerosis (MS), Dementia, Alzheimer's Disease, CACH Syndrome, and Gastric Bypass.

Daniel Ontaneda
Elite in Relapsing Multiple Sclerosis (RMS)
Elite in Relapsing Multiple Sclerosis (RMS)

Cleveland Clinic Main Campus

1950 East 89th Street, 
Cleveland, OH 
Languages Spoken:
English, Spanish

Daniel Ontaneda is a Neurologist in Cleveland, Ohio. Dr. Ontaneda is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, and Encephalitis.

 
 
 
 
Learn about our expert tiers
Learn More
Robert Bermel
Elite in Relapsing Multiple Sclerosis (RMS)
Elite in Relapsing Multiple Sclerosis (RMS)

Cleveland Clinic Main Campus

1950 East 89th Street, 
Cleveland, OH 
Experience:
26+ years
Languages Spoken:
English
Offers Telehealth

Robert Bermel is a Neurologist in Cleveland, Ohio. Dr. Bermel has been practicing medicine for over 26 years and is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

What are the latest Relapsing Multiple Sclerosis (RMS) Clinical Trials?
A Randomized, Double-blind, Parallel-group Study to Compare the Pharmacokinetics, Efficacy, Pharmacodynamics, Safety, and Immunogenicity of CYB704 (Proposed Ocrelizumab Biosimilar) and Ocrevus® (EU-authorized and US-licensed) in Participants With Relapsing Multiple Sclerosis (RMS)

Summary: The goal of this clinical trial is to learn if drug CYB704, a proposed biosimilar to Ocrevus, works to treat multiple sclerosis in the same way as the reference product Ocrevus(R). The main questions it aims to answer are: * Is CYB704 distributed in the body in the same way as the reference product (demonstration of pharmacokinetic (PK) similarity)? * Does have CYB704 the same treatment effect and...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Patients With Multiple Sclerosis

Summary: This study aims to explore the safety, tolerability, cellular kinetics, and pharmacodynamics of P-CD19CD20-ALLO1 in participants with progressive multiple sclerosis (PMS) and relapsing multiple sclerosis (RMS).